Allergen immunotherapy is a global effort in the managing allergic rhinitis. Using questionnaires, we clarified long-term prognosis in children with allergic rhinitis due to house dust. Nasal symptoms improved in 42.1% treated with medicine, compared to 73.5% in those undergoing immunotherapy. Immunotherapy also appears to retard progression from rhinitis to asthma.
